SynthesisFrontiers in oncology2026

Evaluating the efficacy and safety of first-line immunotherapy for metastatic triple-negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials with a focus on PD-L1 expression.

Yanxiao Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.